Hofmann C, Kaiser B, Maerkl S, Duerkop A, Baeumner AJ. Cationic liposomes for generic signal amplification strategies in bioassays. Anal Bioanal Chem. 2020 May;412(14):3383-3393. doi: 10.1007/s00216-020-02612-w. Epub 2020 Apr 6. PMID: 32249343; PMCID: PMC7214507.
PubMed ID: 32249343Li C, Li Q, Wang Z, Han X. Phospholipid Self-Assemblies Shaped Like Ancient Chinese Coins for Artificial Organelles. Anal Chem. 2020 Apr 21;92(8):6060-6064. doi: 10.1021/acs.analchem.0c00430. Epub 2020 Apr 1. PMID: 32207619.
PubMed ID: 32207619Hermann CA, Hofmann C, Duerkop A, Baeumner AJ. Magnetosomes for bioassays by merging fluorescent liposomes and magnetic nanoparticles: encapsulation and bilayer insertion strategies. Anal Bioanal Chem. 2020 Feb 18. doi: 10.1007/s00216-020-02503-0. Epub ahead of print. PMID: 32072208.
PubMed ID: 32072208Imam ZI, Bachand GD. Multicomponent and Multiphase Lipid Nanotubes Formed by Gliding Microtubule-Kinesin Motility and Phase-Separated Giant Unilamellar Vesicles. Langmuir. 2019 Dec 10;35(49):16281-16289. doi: 10.1021/acs.langmuir.9b02637. Epub 2019 Nov 27.
PubMed ID: 31730350Chandra M, Chin YK, Mas C, Feathers JR, Paul B, Datta S, Chen KE, Jia X, Yang Z, Norwood SJ, Mohanty B, Bugarcic A, Teasdale RD, Henne WM, Mobli M, Collins BM. Classification of the human phox homology (PX) domains based on their phosphoinositide binding specificities. Nat Commun. 2019 Apr 4;10(1):1528. doi: 10.1038/s41467-019-09355-y.
PubMed ID: 30948714Jang HS, Cho YK, Granick S. Biologically-active unilamellar vesicles from red blood cells. Biomater Sci. 2019 Mar 26;7(4):1393-1398. doi: 10.1039/c8bm01461b.
PubMed ID: 30663731Burden DL, Kim D, Cheng W, Chandler Lawler E, Dreyer DR, Keranen Burden LM. Mechanically Enhancing Planar Lipid Bilayers with a Minimal Actin Cortex. Langmuir. 2018 Sep 10. doi: 10.1021/acs.langmuir.8b01847. [Epub ahead of print]
PubMed ID: 30149716Burden DL, Kim D, Cheng W, Chandler Lawler E, Dreyer DR, Burden LK. Mechanically Enhancing Planar Lipid Bilayers with a Minimal Actin Cortex. Langmuir. 2018 Aug 27. doi: 10.1021/acs.langmuir.8b01847. [Epub ahead of print]
PubMed ID: 30149716
Avanti Polar Lipids公司是美国著名的磷脂类产品的生产商,该公司主要为各种制药厂和研究机构提供从毫克级到公斤级乃至吨级的磷脂类和甾体类中间体和试剂。为世界范围内的研究机构和制药公司提供 1000 种以上脂类产品,由于其产品的高纯度而享誉全球。40年来,Avanti Polar Lipids公司为世界各地的研究人员和制药公司提供脂类产品。公司的产品不仅范围日益扩大,其纯度之高也是无人能及。
Avanti Polar Lipids, Inc., has a long history of 50 years creating the highest purity lipids available. Our passion for high quality and unique products is only exceeded by our excellent reputation in the marketplace. Although we are known for our lipids, we are More than Lipids. We offer solutions for the entire product cycle…Research to Commercialization.
Avanti Polar Lipids公司的主要产品和服务包括:
(1)Research Products
Highest Purity Lipid Reagents
(2)cGMP Manufacturing
API & Contract Manufacturing
(3)Adjuvants
Immunotherapy & Vaccine Development
(4)Analytical Services
Lipid Analysis
(5)Lipidomics
Mass Spec Standards, Antibodies & Lipid Toolbox
(6)Formulations
Liposomes & Nanoparticles
(7)Equipment
Liposome Production Tools
(8)Custom Services
Synthesis & Beyond